Beam Therapeutics (BEAM) lost more than 10% on Tuesday after announcing updated data from a Phase 1/2 trial for BEAM-302, its gene-editing therapy for a genetic disorder called alpha-1 antitrypsin ...
It's not possible to invest over long periods without making some bad investments. But you have a problem if you face massive losses more than once in a while. So take a moment to sympathize with the ...
FULTON COUNTY, Pa. (WTAJ) — A tractor-trailer hauling steel beams lost its load on the Pennsylvania Turnpike, potentially bringing “Final Destination” type fear to five other drivers. The incident ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results